{"DataElement":{"publicId":"2693227","version":"1","preferredName":"Treatment First Course Biological Response Modifier Administered Number Code","preferredDefinition":"Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at all facilities or the reason they were not given.","longName":"2693225v1.0:2652781v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"2693225","version":"1","preferredName":"Treatment First Course Biological Response Modifier Administered","preferredDefinition":"Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at all facilities or the reason they were not given.","longName":"2691043v1.0:2693223v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2691043","version":"1","preferredName":"Therapeutic Procedure First Course","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:Preceding all others in time or space or degree.:A period of protocol-prescribed activity or intervention.","longName":"C49236:C25509:C25379","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Course","conceptCode":"C25379","definition":"Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3CC3AC65-41F4-6BA0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-18","modifiedBy":"ONEDATA","dateModified":"2007-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2693223","version":"1","preferredName":"Biological Response Modifier Administered","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host.:Given.","longName":"C308:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E483607-E077-13FA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-06","modifiedBy":"ONEDATA","dateModified":"2007-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E483607-E088-13FA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2652781","version":"1","preferredName":"Biological Response Modifier Administered Number Code","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host._The act of having given something (e.g., a medication or test)._Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification._A system of numbered categories for representation of data. [Explanatory Comment: Refer to the FORDS and SEER Program Code Manual for additional instructions.]","longName":"2652781v1.0","context":"PS-CC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"99","valueDescription":"It is unknown whether an immunotherapeutic agent(s) was recommended or administered because it is not stated in patient record; death certificate-only cases.","ValueMeaning":{"publicId":"2652782","version":"1","preferredName":"It is unknown whether an immunotherapeutic agent(s) was recommended or administered because it is not stated in patient record; death certificate-only cases.","longName":"2652782","preferredDefinition":"It is unknown whether an immunotherapeutic agent(s) was recommended or administered because it is not stated in patient record; death certificate-only cases.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B6955E-0E26-0304-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B6955E-0E40-0304-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"88","valueDescription":"Immunotherapy was recommended, but it is unknown if it was administered.","ValueMeaning":{"publicId":"2645267","version":"1","preferredName":"Immunotherapy was recommended, but it is unknown if it was administered.","longName":"2645267","preferredDefinition":"Immunotherapy was recommended, but it is unknown if it was administered.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-503B-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B6955E-0E4C-0304-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"86","valueDescription":"Immunotherapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.","ValueMeaning":{"publicId":"2652784","version":"1","preferredName":"Immunotherapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.","longName":"2652784","preferredDefinition":"Immunotherapy was not administered. It was recommended by the patient's physician, but was not administered as part of first-course therapy. No reason was stated in the patient record.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B6955E-0E7F-0304-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B6955E-0E99-0304-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"85","valueDescription":"Immunotherapy was not administered because the patient died prior to planned or recommended therapy.","ValueMeaning":{"publicId":"2645270","version":"1","preferredName":"Immunotherapy was not administered because the patient died prior to planned or recommended therapy.","longName":"2645270","preferredDefinition":"Immunotherapy was not administered because the patient died prior to planned or recommended therapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31B567BF-50AD-2C18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-30","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B6955E-0EA5-0304-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"82","valueDescription":"Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors","ValueMeaning":{"publicId":"2652785","version":"1","preferredName":"Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors","longName":"2652785","preferredDefinition":"Immunotherapy was not recommended/administered because it was contraindicated due to patient risk factors (i.e., comorbid conditions, advanced age).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B6955E-0EB2-0304-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B6955E-0ECC-0304-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"01","valueDescription":"Immunotherapy administered as first course therapy.","ValueMeaning":{"publicId":"2652786","version":"1","preferredName":"Immunotherapy administered as first course therapy.","longName":"2652786","preferredDefinition":"Immunotherapy administered as first course therapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B6955E-0ED8-0304-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B6955E-0EF2-0304-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"00","valueDescription":"None, immunotherapy was not part of the planned first course of therapy.","ValueMeaning":{"publicId":"2652787","version":"1","preferredName":"None, immunotherapy was not part of the planned first course of therapy.","longName":"2652787","preferredDefinition":"None, immunotherapy was not part of the planned first course of therapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B6955E-0EFE-0304-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32B6955E-0F18-0304-E044-0003BA3F9857","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2007-06-12","deletedIndicator":"No"},{"value":"87","valueDescription":"Immunotherapy was not administered. It was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.","ValueMeaning":{"publicId":"3270794","version":"1","preferredName":"Immunotherapy was not administered. It was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.","longName":"3270794","preferredDefinition":"Immunotherapy was not administered. It was recommended by the patient's physician, but this treatment was refused by the patient, the patient's family member, or the patient's guardian. The refusal was noted in the patient record.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACC1CCA5-3FE4-7039-E040-BB89AD431322","latestVersionIndicator":"Yes","beginDate":"2011-09-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACC1CCA5-3FFD-7039-E040-BB89AD431322","beginDate":"2011-09-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-12","modifiedBy":"ONEDATA","dateModified":"2011-09-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2662248","version":"1","preferredName":"Biological Response Modifier Administered Number Code","preferredDefinition":"Substances or procedures that enhance the host's ability to inhibit tumorigenesis or tumor progression or that increase the differential between tumor and host susceptibility to therapeutic agents. Thus BRMs can be preventive (vaccines, vitamins) or therapeutic (interferon, monoclonal antibodies, hyperthermia, gene therapy.) Standard, nonspecific therapies such as drugs and radiation are excluded but radiation delivered via antibodies would be included since it exploits a differential susceptibility of tumor and host.:Given.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.:A system of numbered categories for representation of data.","longName":"C308:C25382:C25337:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34851111-A6F1-0E8C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-05","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-07-05","modifiedBy":"ONEDATA","dateModified":"2007-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32B7509E-3CDC-7045-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"CURTIST","dateCreated":"2007-06-12","modifiedBy":"CURTIST","dateModified":"2011-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3103505","version":"1","longName":"NAACCR 11.1","context":"PS-CC"},{"publicId":"3103506","version":"1","longName":"NAACCR 11.2","context":"PS-CC"},{"publicId":"3103507","version":"1","longName":"NAACCR 11.3","context":"PS-CC"},{"publicId":"5899849","version":"1","longName":"Treatment1stCourse16","context":"PS-CC"},{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464323","version":"1","longName":"Treatment1stCourse18","context":"PS-CC"}]}],"AlternateNames":[{"name":"1410","type":"NAACCR Item #","context":"PS-CC"},{"name":"Biological Response Modifiers (pre-96 SEER)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"Immunotherapy (SEER/COC)","type":"NAACCR Alt Name","context":"PS-CC"},{"name":"RX SUMM--BRM ","type":"NAACCR Item Name","context":"PS-CC"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"TX_SUMM_BRM_CD","type":"C3D Name","context":"NCIP"},{"name":"RX Summ--BRM","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Immunotherapy (SEER/CoC)","type":"NAACCR Alt Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"RX Summary Biological Respons","type":"Preferred Question Text","description":"RX Summary Biological Response Modifier","url":null,"context":"PS-CC"},{"name":"NAACCR, V 11.1 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.1 Data Standards and Data Dictionary (5/4/06)","url":"http://www.naaccr.org/filesystem/pdf/Volume%20II%20Version%2011.1.pdf","context":"PS-CC"},{"name":"RX Summ--BRM Description","type":"COMMENT","description":"Immunotherapy consists of biological or chemical agents that alter the immune system or change the host's response to tumor cells.","url":null,"context":"PS-CC"},{"name":"Immunotherapy/Biologic Response Modifier (BRM)","type":"Alternate Question Text","description":"Immunotherapy/Biologic Response Modifier (BRM)","url":null,"context":"NCIP"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"NAACCR V11.2 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.2 Data Standards and Data Dictionary (5/30/2007)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=PQdlAnykU1U%3d","context":"PS-CC"},{"name":"NAACCR V11.3 Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 11.3 Data Standards and Data Dictionary (4/2008)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=xSH32ZzIzGI%3d","context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E483607-E09D-13FA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-11-06","modifiedBy":"DWARZEL","dateModified":"2022-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}